Evidence map›Paper›PMID 27283324›Full record

ArticleClinical oral investigations2017

Increased visfatin expression is associated with nuclear factor-kappa B and phosphatidylinositol 3-kinase in periodontal inflammation.

Erkan Özcan, N Işıl Saygun, Rahşan Ilıkçı, Yıldırım Karslıoğlu, Uğur Muşabak, Sait Yeşillik

Abstract read
PubMed Publisher
In one paragraph

Article in Clinical oral investigations, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 3 pooled it
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 3 syntheses or guidelines pooled it, 45 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Inhibition of visfatin alleviates sepsis-induced intestinal damage by inhibiting Hippo signaling pathway.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2022
    Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Erkan ÖzcanDepartment of Periodontology, Gülhane Military Medicine Academy, Dental Sciences Center, Ankara, Turkey. drdterkan@mynet.com.
N Işıl SaygunDepartment of Periodontology, Gülhane Military Medicine Academy, Dental Sciences Center, Ankara, Turkey.
Rahşan IlıkçıDepartment of Immunology, Gülhane Military Medicine Academy, Ankara, Turkey.
Yıldırım KarslıoğluDepartment of Pathology, Gülhane Military Medicine Academy, Ankara, Turkey.
Uğur MuşabakDepartment of Immunology, Gülhane Military Medicine Academy, Ankara, Turkey.
Sait YeşillikDepartment of Immunology, Gülhane Military Medicine Academy, Ankara, Turkey.
Turkish Armed Forces · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveVisfatin is an adipocytokine that plays a role in regulating periodontal inflammation by as yet identified mechanisms. It has been suggested that visfatin mediates inflammation via activation of the nuclear factor-kappa B (NF-κB) and phosphatidylinositol 3-kinase (PI3k) signaling pathways which play a role in the inhibition of neutrophil apoptosis. The aim of this study was to investigate the expression of visfatin, NF-κB (NF-κB MATERIALS AND

methodsTissue biopsy samples were obtained from 21 patients with chronic periodontitis and from the gingiva of 19 healthy individuals undergoing crown lengthening. The mRNA expression levels of visfatin, NF-κB, PI3k, TNF-α, and IL-1β were evaluated by quantitative real-time PCR (qPCR). Also, visfatin protein expression was measured by immunohistochemistry.

resultsBoth qPCR and immunohistochemistry results revealed that the visfatin expression was higher in the tissues with periodontitis than in healthy tissues (P < 0.01). Similarly, the mRNA expression levels of NF-κB

conclusionsOur results demonstrated that increased visfatin was associated with the expression of NF-κB and PI3k which may play a role in the pathogenesis of periodontitis. We suggest that increased visfatin may contribute to the inhibition of neutrophil apoptosis via the NF-κB and PI3k signaling pathways. CLINICAL RELEVANCE: Understanding the role of visfatin in periodontitis will enable the development of new treatment methods for inflammation.

Indexed as

AdultChronic PeriodontitisCytokinesFemaleHumansImmunohistochemistryInterleukin-1betaMaleNF-kappa BNicotinamide PhosphoribosyltransferasePhosphatidylinositol 3-KinaseReal-Time Polymerase Chain ReactionRNA, MessengerTumor Necrosis Factor-alphaCytokinesInterleukin-1betaNF-kappa BNicotinamide Phosphoribosyltransferasenicotinamide phosphoribosyltransferase, humanPhosphatidylinositol 3-KinaseRNA, MessengerTumor Necrosis Factor-alphaApoptosisNicotinamide phosphoribosyltransferaseNuclear factor-kappa BPeriodontitisPhosphatidylinositol 3-kinase

Identifiers

PMID27283324
OpenAlexW2417861482

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.